Catarina Lima Vieira

Catarina Lima Vieira

Auto-generated profile, based on publicly available information

Catarina Lima Vieira

Medical Doctor, Department of Anesthesiology, Hospital Pedro Hispano, Matosinhos, Portugal

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2018 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
BABruno Frota Amora-Silva
Bruno Frota Amora-Silva
SRS. C. Ribeiro
S. C. Ribeiro
CVC. L. Vieira
C. L. Vieira
FMFrancisco Rogenio da Silva Mendes
Francisco Rogenio da Silva Mendes
AVAntonio Eufrasio Eufrasio Vieira-Neto
Antonio Eufrasio Eufrasio Vieira-Neto
ACAdriana Rolim Campos
Adriana Rolim Campos

17 February 2021 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
ICInês Rio Coles
Inês Rio Coles
CVCatarina Lima Vieira
Catarina Lima Vieira
IGIsabel Barroco Gouveia
Isabel Barroco Gouveia
TRTeresa Rebelo
Teresa Rebelo
LALuís Agualusa
Luís Agualusa
Chronic heel pain is a challenging diagnosis and although it is a common and disabling condition frequently mistreated. Baxter Nerve (BN) entrapment is responsible for 20% of heel pain and can be managed by an ultrasound guide nerve block, a simple, safe, and durable technique. A 67-year-old woman complained of paraesthesia on the left heel and a “stepping on glass” feeling. Various techniques were performed to manage her symptoms without any results. An ultrasound BN block was finally performed with an instant relief and satisfactory pain control for the follow-up period of six months. This clinical report highlights the success of the ultrasound BN block as an effective and lasting solution for chronic heel pain.

29 February 2016 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
Fernando MagroFernando Magro
Fernando Magro
JRJaime Ramos
Jaime Ramos
LCLuís Correia
Luís Correia
PLPaula Lago
Paula Lago
PPPaula Maria Cordeiro Dores Rodrigues Peixe
Paula Maria Cordeiro Dores Rodrigues Peixe
SFSamuel Fernandes
Samuel Fernandes
Introduction: Anaemia can be considered the most common extra-intestinal manifestation in inflammatory bowel disease. Nevertheless, anaemia is often under-diagnosed and under-treated both in adults and children with inflammatory bowel disease. Herein, we report the consensus statements on the management of anaemia in inflammatory bowel disease developed by the Portuguese Working Group on Inflammatory Bowel Disease (known as Grupo de Estudo da Doença Inflamatória Intestinal - GEDII) to aid clinicians in daily management of inflammatory bowel disease patients. Material and Methods: A comprehensive literature review was conducted in order to prepare consensus statements on the following topics: (1) prevalence and diagnosis of anaemia in inflammatory bowel disease, (2) iron supplementation for the prevention of anaemia in inflammatory bowel disease and (3) treatment of anaemia in inflammatory bowel disease. The final statements for each topic were discussed at a consensus meeting and rated according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. Consensus: It was concluded that anaemia has a high incidence and prevalence in inflammatory bowel disease, particularly in those with active disease and hospitalised. Patients with anaemia had decreased quality of life and frequently complained of fatigue. Absolute indications for intravenous therapy should be considered: (1) moderate to severe anaemia (haemoglobin < 10.5 g/dL) or clearly symptomatic anaemia; (2) previous intolerance to oral iron supplements; (3) inappropriate response to oral iron; (4) active severe intestinal disease; (5) need for a quick therapeutic response (e.g. surgery in the short term); (6) concomitant therapy with erythropoiesis-stimulating agent; and (7) patient’s preference.